Cargando…
Stromal tenascin distribution as a prognostic marker in colorectal cancer.
A total of 169 colorectal adenocarcinomas, obtained from patients with a median follow-up of 6.5 years, were studied with immunohistochemical staining on cryosections using a monoclonal anti-tenascin antibody to evaluate the possible association between the staining patterns and tumour stage, tumour...
Autores principales: | Kressner, U., Lindmark, G., Tomasini-Johansson, B., Bergström, R., Gerdin, B., Påhlman, L., Glimelius, B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2227978/ https://www.ncbi.nlm.nih.gov/pubmed/9275031 |
Ejemplares similares
-
Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer.
por: Kressner, U., et al.
Publicado: (1998) -
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor
por: Salahshor, S, et al.
Publicado: (1999) -
Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.
por: Palmqvist, R., et al.
Publicado: (1998) -
The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.
por: Lindmark, G., et al.
Publicado: (1995) -
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)